chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Minor ache in bones, mainly in knees and ankle; stiffness in my arm around the shot area; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Minor ache in bones, mainly in knees and ankle) and MUSCULOSKELETAL STIFFNESS (stiffness in my arm around the shot area) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 immunisation.     Concurrent medical conditions included Hypertension, Diabetes and Hyperlipidemia. Concomitant products included AMLODIPINE for Blood pressure abnormal, ROSUVASTATIN for Cholesterol, METFORMIN for Diabetes, ACETYLSALICYLIC ACID (ASPIRINE), GABAPENTIN, LEVOTHYROXINE, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE (SYNJARDY) and DULAGLUTIDE (TRULICITY).    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced BONE PAIN (Minor ache in bones, mainly in knees and ankle) and MUSCULOSKELETAL STIFFNESS (stiffness in my arm around the shot area). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 milligram. At the time of the report, BONE PAIN (Minor ache in bones, mainly in knees and ankle) and MUSCULOSKELETAL STIFFNESS (stiffness in my arm around the shot area) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitantly, patient was taking one med agent that could not get it right: 0.5 mg two twice a week.
( H/O bilateral mastectomies with reconstruction and right breast radiation in 2014.)  New onset right breast discoloration, discomfort, and swelling that started three days after second dose of COVID vaccine.  Vaccine was given in right arm. There are no s/s of bacterial infection, no fever, chills, or drainage.
Patient has developed a rash on his left wrist/hand/knuckle area which has become very red/purple, tingling, and stings
Marked fatigue over 3-4 days, assoc with generalized body aches.
Tiredness; sleepy; headache; malaise; This is a spontaneous report from a contactable Other HCP (patient). A 55-year-old female (not pregnant) patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided), intramuscular in arm Left on 16Dec2020 12:45 at single dose for COVID-19 immunisation. Medical history included none. No allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient experienced tiredness, sleepy, headache, malaise on 16Dec2020 16:00. The patient underwent lab tests and procedures which included Nasal Swab: negative on unknown date in Dec2020.  The patient not received any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has been tested for COVID-19. No treatment received for the adverse event. Case was non-serious. The outcome of events was recovered in Dec2020.  Information on the Batch/Lot number has been requested.
Next afternoon, Wednesday, approx. 26 hours after injection - chilled and tired. Next evening, Wednesday, approx. 29 hours after injection - tried to eat some instant mashed potatoes (make with water , butter and a bit of salt) = tasted extremely salty. And two smoked sausages. Forced myself to finish it all (normal serving sizes for me) and about half-way through felt like I was going to throw up! Kept it down. Fell asleep for about 2 hours, got up, used restroom and back to sleep - 12 hours! Friday evening right upper arm itchy - Saturday morning noticed rash on upper right arm - about the size of my hand - to the backside of injection site. Sunday afternoon - upper left arm itchy with rash like right arm.
Patient was hospitalized for one week and received seven weeks of rehabilitation to regain body strength to be able to walk and still receiving therapy.
Pt. reported feeling dizziness following vaccine.  Pt. was placed in recumbent position, vitals were taken and wnl.  Pt. stated he feels better and was released home with mom after observation time was completed.
large red area surrounding site of immun;pt screaming w/in 30min of vax;fussy w/dec appetite, but not fever;no tx required;pt was better on 2DEC97;
Pt thinks she received all of her vaccinations in her right upper arm. She denies experiencing any unusual or prolonged redness, tenderness or swelling surrounding her vaccination sites, and denies experiencing symptoms consistent with an immediate hypersensitivity reaction, such as angioedema, hives/rashes, swelling of mouth and throat, cardiovascular, respiratory, and GI symptoms within the first 4-8 hours of vaccine administration. Within 24 hours of vaccine receipt, pt noted headache, fatigue, and joint and muscle pain. Joint and muscle pain described as generalized stabbing and shooting pains that increased over the next 48 hours to an intensity level of 8/10, using intensity scale from 0 (= no pain) to 10 (= worst pain ever experienced). Pain described as being "like sharp needles all the time" and sometimes like a "hot poker stabbing". On 16 Apr 2014, patient was taken to Emergency Room (ER) for evaluation of pain, as well as for tingling and numbness and swelling of hands and feet and face. Diagnosed with "paresthesias" and "edema". [No ER records available except discharge instructions and lab results.] Labs included normal CMP, CK, CBC with mild anemia, and elevated ESR. Referred to Neurology. On 6 Jun 2014, patient was evaluated by neurology. Pt reported numbness and tingling in both great toes, and pain in RLE below knee and RUE. She also noted increased clumsiness. No dizziness, changes in bladder/bowel control, hearing, hand coordination, walking and balance noted. No other focal neurological problems noted. Physical exam was normal. Assessment: paresthesias and pain in RLE, RUE. No diagnostics were ordered. [Pt reports she continued to experience intense pain diffusely in her muscles and joints.] On 18 Jul 2014, pt had a follow up appointment with neurology. She continued to report tingling and pains in the backs of her legs and in her feet, as well as pain in her joints. Pain present in joints of bilateral UE (right > left), with some muscle cramps in both hands. Pain primarily in knees, ankles, and elbow. One week prior to appointment, patient noted onset of right-sided neck pain. Pt also reported she was more forgetful and had some trouble thinking clearly. Physical exam assessing the following were normal: extremity strength, motor and gait, coordination, sensory, coordination, DTRs and Babinski Impression: Pain and paresthesias in all extremities (RUE>LUE, LLE>RLE). Plan: ESR, CRP; NCS/EMG of upper and lower extremities to rule out neuropathy, radiculopathy. On 12 Sep 2014, pt was evaluated by neurology for follow up evaluation. She reported diffuse joint and muscle pain, fatigue, hot flashes, and intermittent swelling in the joints, as well as tingling, especially in the feet. Neurological exam was normal. Impression: possible fibromyalgia. Plan: MRI, brain to rule out demyelinating disease. Referral to rheumatology. On 19 Mar 2015, pt had initial consult with rheumatology. She presented for evaluation of chronic pain since Apr 2014 following receipt of immunizations. Pt reported diffuse joint pain and was diagnosed myofascial pain which continues today.
Patient received vaccine on 11/5/2021. On 11/6/2021, patient reported development of acute-onset shortness of breath and dyspnea on exertion. He had progressively worsening symptoms through 11/11/21 after which he presented to the Hospital for further evaluation. He also endorsed progressively worsening pleuritic chest pain. He subsequently was found to have a saddle pulmonary embolism with extensive emboli in the segmental and subsegmental branches of all lobes. He was started on therapeutic anticoagulation with enoxaparin 1mg/kg twice daily with plan to transition to oral rivaroxaban. After initiation of anticoagulation, patient endorsed improvement in dyspnea.
Rash on left shoulder, 2 inches diameter around injection site. Skin is raised, red, and firm. No itching, no sensitivity to touch.  Small ring of redness around area for past week, sudden increase to firm skin and rash within last 6 hours. No other symptoms.
This report describes the occurrence of an allergic reaction in a 53 year old female who was vaccinated with hepatitis B vaccine recombinant (Engerix-B) for prophylaxis. This report was received from the subject and has not been verified by a physician or other healthcare professional.  The subject's medical history reportedly included menopause.  Reportedly, the subject had no known drug allergies and no adverse experiences following previous immunizations.  The subject stated that her concurrent medications included montelukast sodium (Singulair), fexofenadine hydrochloride (Allegra), "shots at the allergists", and unspecified vitamins.  The subject stated that on 05/12/03, she received her first injection of Engerix-B; 48 hours post-immunization she developed an allergic reaction characterized by nausea, "slight" fever, soreness in her throat, weakness, and pain and swelling in her joints.  The subject stated that she was seen by a physician. The subject reported that the nausea, fever and sore throat resolved after one day; the weakness and joint swelling resolved after a "few" days.  As of 05/22/03, the joint pain persisted.
Metallic taste approximately three hours post immunization, followed by "sours" on inside cheeks of mouth approximately five hours after injection. "Sores" ruptured and have resolved on their own by 1/27/22,  no interventions required for treatment.
5 days of the worst migraines you ever had. I pat my head with ice. Took the Reyvow which put me to sleep. Real bad nauseas but I didn't throw up or have diarrhea. Just the migraines that were really bad. I never had migraines this bad until I received all these injections. The oxygen I take at night didn't start until I took the Covid injections. I am still saying thank you for them.
headache with sore muscles, no fever, flu shot received on 10/6/2021 (2 days before adverse effect)
Developed hives 1 day after immunization. Took Claritin with some relief.
Admitted for COVID pneumonitis. Diagnosed 3 days PTA. Fully vaccinated. Treated with lovenox, lasix, vit-c, zinc, steroids, O2. No remdesivir due to acute renal failure. Weaned to RA eventually and discharged to SNF. When seen this morning he denied any shortness of breath, chest pain or cough.  He was on 0.5 L of supplemental oxygen during my visit but then that was also turned off.  No nausea.  Reported that his appetite is back once he had a bowel movement yesterday morning.  No abdominal pain.  Passing flatus.  He is overall feeling better and his eager to go to skilled nursing facility to recover further.  Called and updated daughter in detail.
severe arm pain from the first dose and trouble sleeping due to pain; severe arm pain from the first dose and trouble sleeping due to pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (severe arm pain from the first dose and trouble sleeping due to pain) and INSOMNIA (severe arm pain from the first dose and trouble sleeping due to pain) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 09AB21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN, GLIPIZIDE, FENOFIBRATE, LISINOPRIL, LEVOTHYROXINE, TOPIRAMATE, OMEPRAZOLE and LIRAGLUTIDE (VICTOZA) for an unknown indication.    On 09-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced PAIN IN EXTREMITY (severe arm pain from the first dose and trouble sleeping due to pain) and INSOMNIA (severe arm pain from the first dose and trouble sleeping due to pain). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) for Adverse event, at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (severe arm pain from the first dose and trouble sleeping due to pain) and INSOMNIA (severe arm pain from the first dose and trouble sleeping due to pain) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-407138 (Patient Link).
Well so on June 4th 2021 I got a positive pregnancy test via blood in the Hospital. On July 12th I would have been 9.5 weeks pregnant. I went to a regular ultrasound appointment and there was an early miscarriage. On July 22, I had a DNC procedure due to the early/silent miscarriage.
More than 35 days since the first shot; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 35 days since the first shot) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 35 days since the first shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 35 days since the first shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Patient took second dose on 14AUGUST2021 AT 13:06PM with batch number 062E21A. Treatment information was not provided.  Pharmacist reported that patient was at the pharmacy to receive the second dose, but the first dose was given on 20 May 2021.   Most recent FOLLOW-UP information incorporated above includes: On 25-Aug-2021: Follow up contains no new information.
Diarrhea started four hours after vaccination. Has muscle pains. Feels hot then cold getting goose bumps. Bends over, when she gets up feels like she is blacking out.
Dizzy; Nauseous; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), NAUSEA (Nauseous) and VOMITING (Vomiting) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was hanged to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jul-2021, the patient experienced DIZZINESS (Dizzy), NAUSEA (Nauseous) and VOMITING (Vomiting). At the time of the report, DIZZINESS (Dizzy), NAUSEA (Nauseous) and VOMITING (Vomiting) outcome was unknown.  NO Concomitant information was reported. No treatment information was reported.
1 of 3 pt recv vax from the same vial who exp a local rxn;event occurred 3-5 days following vax, described as local redness-4" in diameter @ inj site w/soreness;MD visit-ice recommended for tx-recovered;
Received 100mcg Moderna COVID-19 booster rather than approved 50mcg dose.
Sleeping all the time; Patient was shaking; Muscle aches; Joint aches; Very bad headache; Patient had chills; Fever; This spontaneous case was reported by a patient and describes the occurrence of SOMNOLENCE (Sleeping all the time), TREMOR (Patient was shaking), MYALGIA (Muscle aches), ARTHRALGIA (Joint aches) and HEADACHE (Very bad headache) in a 70-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Suspected COVID-19 (Patient didn't get tested, but believes had COVID on March 2022) in March 2022. Concurrent medical conditions included Gluten sensitivity and Nickel sensitivity.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (Sleeping all the time), TREMOR (Patient was shaking), MYALGIA (Muscle aches), ARTHRALGIA (Joint aches), HEADACHE (Very bad headache), CHILLS (Patient had chills) and PYREXIA (Fever). At the time of the report, SOMNOLENCE (Sleeping all the time), TREMOR (Patient was shaking), MYALGIA (Muscle aches), ARTHRALGIA (Joint aches), HEADACHE (Very bad headache), CHILLS (Patient had chills) and PYREXIA (Fever) outcome was unknown.            Concomitant mediations were not reported.   There weren't any other vaccines given to the patient within 1 month prior to the Moderna CVIS-19 vaccine.  Patient states that symptoms were very intense for first 24 hours.  For treatment patient took her own medicine.   This case was linked to MOD-2022-584256.
BED RIDDEN; CHILLS; HIGH FEVER; This spontaneous report received from a consumer via a company representative concerned an adult male. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced bed ridden, chills, and high fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bed ridden, high fever and chills was not reported. This report was non-serious.
CHILLS; FEVER; MILD HEADACHE; BODY ACHES AND PAINS; DIARRHEA; This spontaneous report received from a patient concerned a 47 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included familial tremors, non alcohol user, and smoker, and other pre-existing medical conditions included the patient had no known allergies and did not had drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805025, and expiry: UNKNOWN) dose was not reported, administered on 22-MAR-2021 for prophylactic vaccination on left arm. Concomitant medications included propranolol, and venlafaxine hydrochloride. On 22-MAR-2021, the subject experienced diarrhea. On 23-MAR-2021, the subject experienced body aches and pains. On 23-MAR-2021, the subject experienced fever. On 23-MAR-2021, the subject experienced mild headache. On an unspecified date, the subject experienced chills. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea on 22-MAR-2021, and body aches and pains, fever, and mild headache on 23-MAR-2021, and the outcome of chills was not reported. This report was non-serious.
injection site itchy; injection site swelling; injection site sore to touch; injection site red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE PAIN (injection site sore to touch) and VACCINATION SITE ERYTHEMA (injection site red) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for COPD, LISINOPRIL, AMLODIPINE, ATENOLOL, ROSUVASTATIN, WARFARIN and ALPRAZOLAM for an unknown indication, SALBUTAMOL (VENTOLIN [SALBUTAMOL]).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE PAIN (injection site sore to touch) and VACCINATION SITE ERYTHEMA (injection site red). At the time of the report, VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE PAIN (injection site sore to touch) and VACCINATION SITE ERYTHEMA (injection site red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Non-significant FU added.Fax Number Updated
Approximately 13 hours after the shot I became very cold and shivered violently and uncontrollably for about 45 minutes. I also had muscle and joint pain throughout my body)( so strong that I could not sleep), yet I was very fatigued. These symptoms (except for the 45-minutes of shivering) lasted throughout the following day, along with headache.  Pain in my right arm took about a week to resolve.
Patient or vaccinator unable to state if patient received dose of vaccine  due to needle retracting during administration of vaccine.  Vaccine noted oozing from syringe from patient arm
Hives; This is a spontaneous report from a non-contactable physician. A 31-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 27Dec2020 in left arm at single dose for COVID-19 immunization. Medical history included rheumatoid arthritis and known allergies to fire ants from an unknown date and unknown if ongoing. Concomitant medication included etanercept (ENBREL) and drospirenone, ethinylestradiol (YASMIN). The patient experienced hives in Dec2020. The facility where the most recent COVID-19 vaccine was administered was on the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was recovered in Dec2020. Therapeutic measure such as anti-histamine was taken as a result of hives. The event was considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.  No follow-up attempts are possible, information about lot/batch cannot be obtained.
I add swollen lymph nodes underarm a day following vaccine. However, what I am more concerned about is that my right breast (side of right breast) is now firm and feels like a nodule. I did not have this before the vaccine. I am 5 months post my vaccinations and this is still there. My underarm lymph node swelling in the right arm went down after a few days from the time I got the vaccination. However, my breast tissue (perhaps even breast lymph node) still is not back to normal. I just had a mammogram in December (1 month prior to getting the COVID vaccine) and checked out fine on the 3D mammogram as well as the ultrasound. I am going to call my OBGYN to have him feel my breast and see if I need to go back for another mammogram. This will be good to see if anything has changed from pre-COVID vaccine to post-COVID vaccine.